Establishment of leukemia inhibitory factor (LIF)-independent iPS cells with potentiated Oct4

Hiroyuki Hirai, Meri Firpo, Nobuaki Kikyo

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

Leukemia inhibitory factor (LIF) is widely used to establish and maintain naïve pluripotent stem cells, including mouse embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs). Although the combination of chemical inhibitors called 2i can establish mouse iPSCs without LIF from primed pluripotent stem cells, it has been difficult, if not impossible, to establish mouse iPSCs from differentiated somatic cells without LIF. We previously showed that the fusion gene of the transactivation domain of MyoD and the full-length Oct4 (M3O) increases the efficiency of making iPSCs when transduced into fibroblasts along with Sox2, Klf4, and c-Myc (M3O-SKM). Here, we report that M3O-SKM allows for establishment of iPSCs without exogenous LIF from mouse embryonic fibroblasts. The established iPSCs remained undifferentiated and maintained pluripotency over 90days without LIF as long as M3O was expressed. The iPSCs upregulated miR-205-5p, which was potentially involved in the LIF-independence by suppressing the two signaling pathways inhibited by 2i. The result indicates that potentiated Oct4 can substitute for the LIF signaling pathway, providing a novel model to link Oct4 and LIF, two of the most significant players in naïve pluripotency.

Original languageEnglish (US)
Pages (from-to)469-480
Number of pages12
JournalStem Cell Research
Volume15
Issue number3
DOIs
StatePublished - Nov 1 2015

Keywords

  • Induced pluripotent stem cells
  • Leukemia inhibitory factor
  • Pluripotency
  • miRNA

Fingerprint Dive into the research topics of 'Establishment of leukemia inhibitory factor (LIF)-independent iPS cells with potentiated Oct4'. Together they form a unique fingerprint.

  • Cite this